Clinical and Translational Research
Copyright ©The Author(s) 2024.
World J Clin Oncol. Jan 24, 2024; 15(1): 89-114
Published online Jan 24, 2024. doi: 10.5306/wjco.v15.i1.89
Figure 7
Figure 7 Differential analysis of tumor mutation burden and tumor immune dysfunction and exclusion. A and B: Waterfall plots depicting 15 highly mutated genes in the high- and low-risk colorectal cancer (CRC) groups; C: Differential analysis of TMB in patients from the high- and low-risk CRC groups; D: Tumor immune dysfunction and exclusion analysis in patients from the high and low-risk groups. aP < 0.05; bP < 0.01; cP < 0.001.